“Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models” (2025) The Review of Diabetic Studies, pp. 1–21. doi:10.1900/q356v768.